Nigerian Agency for Food and Drug Administration and Control known as NAFDAC has approved the production of Chloroquine for clinical trials in fighting the deadly Wuhan virus that has affected almost 190 countries around the world.
The announcement was made on Friday at the NAFDAC headquarters in Lagos by Director-General of the agency, Mojisola Adeyeye after Trump says on Thursday FDA will fast-track treatments for the novel coronavirus with Chloroquine.
She, however, NAFDAC is not approving Chloroquine for the treatment of coronavirus yet but for clinical trials to be sure if the drug will be active as been speculated in the media.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials,” NAFDAC director says.
